Stenotrophomonas (Xanthomonas) maltophilia: A Multidrug‐Resistant Nosocomial Pathogen
- 4 March 1997
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 17 (2) , 293-301
- https://doi.org/10.1002/j.1875-9114.1997.tb03712.x
Abstract
Stenotrophomonas (Xanthomonas) maltophilia is emerging as a multidrug-resistant nosocomial pathogen. In general, the organism is opportunistic, colonizing or infecting patients with predisposing risk factors such intensive care unit residence, malignancy, mechanical ventilation, and previous antibiotic exposure. It can cause a variety of infections depending on underlying patient-specific medical conditions. It is often part of multimicrobial infections, and determining its role as a pathogen is difficult. Trimethoprim-sulfamethoxazole (TMP-SMX) has traditionally been the most active agent against S. maltophilia. Other classes of antibiotics, with few exceptions, have not been effective. Synergistic antimicrobial combinations are now being investigated due to the bacteriostatic nature of TMP-SMX, and increasing reports of resistance to TMP-SMX. The combination of ticarcillin-clavulanate plus TMP-SMX appears to be the most promising regimen studied thus far.This publication has 81 references indexed in Scilit:
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- Prevalence of ciprofloxacin resistance in multiresistant gram-negative intensive care unit isolatesInfection, 1994
- XANTHOMONAS MALTOPHILIA BACTEREMIA: AN ANALYSIS OF FACTORS INFLUENCING OUTCOMEInfectious Diseases in Clinical Practice, 1992
- Susceptibility to -lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 -lactamasesJournal of Medical Microbiology, 1991
- Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1991
- The barrier function of the outer membrane ofPseudomonas maltophiliain the diffusion of saccharides and β-lactam antibioticsFEMS Microbiology Letters, 1989
- Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitorsDiagnostic Microbiology and Infectious Disease, 1989
- Clinical significance of beta-lactamase induction and stable derepression in gram-negative rodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Pharmacokinetics of Intravenous Trimethoprim-Sulfamethoxazole in Children and Adults with Normal and Impaired Renal FunctionClinical Infectious Diseases, 1982
- Prosthetic Valve EndocarditisCirculation, 1973